US approves first rapid home Covid-19 test

0:00
play article
Subscribers can listen to this article
  • The US has authorised a rapid coronavirus test.
  • The Lucira Health test delivers results in 30 minutes.
  • It's intended to cost less than $50.


The US issued an emergency use authorisation for the first self-administered rapid coronavirus test on Tuesday, as more parts of the country increase restrictions in an attempt to halt a Covid-19 surge.

LIVE | All the latest coronavirus and lockdown updates

The Food and Drug Administration approved a testing kit for people age 14 and older whom a doctor suspects to have Covid-19. The test, which is by prescription only, delivers results in 30 minutes.

"We continue to demonstrate unprecedented speed in response to #COVID19," tweeted FDA commissioner Stephen Hahn.

"FDA authorized the first #COVID19 test that's fully self-administered & provides results at home. It's an important advancement, underscoring our commitment to expanding test access."

The authorisation is for an at-home nasal sample kit developed by Lucira Health. Users collect a sample with the included nasal swab, then put the sample in a small vial.

The vial is inserted into a small device that tests the sample. A light-up display on the device shows a user's result in 30 minutes or less.

The test is designed to be affordable and is intended to cost less than $50, according to the Lucira Health website.

The FDA had previously approved at-home Covid-19 tests, giving the green light in late April and early May to two nasal sample collection kits and one saliva sample collection kit.

But samples from those kits had to be sent to a lab for processing, instead of delivering results at home.

While the Lucira test provides results on the spot, it still isn't the kind of cheap and rapid antigen test that some researchers have called to use for large-scale population screening.

As of Tuesday, the US had recorded 11 340 563 coronavirus cases with 248 429 deaths, according to Johns Hopkins University. Both tolls are by far the worst in the world.

Do you want to know more about this topic? Sign up for one of News24's 33 newsletters to receive the information you want in your inbox. Special newsletters are available to subscribers.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
When planning for the Black Friday sales do you:
Please select an option Oops! Something went wrong, please try again later.
Results
Save, research and plan ahead, preparing to make the most of it?
8% - 849 votes
Wait and see what looks like a good deal on the day?
14% - 1606 votes
Have no interest in spending more money this year?
78% - 8705 votes
Vote
ZAR/USD
15.43
(-0.02)
ZAR/GBP
20.51
(+0.03)
ZAR/EUR
18.25
(+0.28)
ZAR/AUD
11.22
(+0.51)
ZAR/JPY
0.15
(+0.53)
Gold
1837.30
(-1.79)
Silver
23.50
(-2.73)
Platinum
921.00
(-2.28)
Brent Crude
45.18
(0.00)
Palladium
2338.48
(+1.23)
All Share
57147.31
(+0.94)
Top 40
52478.55
(+1.08)
Financial 15
11337.90
(+0.62)
Industrial 25
79917.53
(+1.49)
Resource 10
51771.17
(+0.65)
All JSE data delayed by at least 15 minutes morningstar logo